Key facts
- Notable investors include Hyundai Venture Investment Corporation, Company K Partners, DSC Investment, HB Investment, Healing Paper — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Ultra V
- ·The full record, as it builds
Funding rounds
No funding rounds for Ultra V are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ultra V
Developer of medical devices and functional cosmetics designed for performing dermatology and plastic surgery. The company's products are infused with special polydioxanone (PDO), an absorbable thread used in medical applications and also cosmetics, mainly focused on anti-aging products, enabling medical institutions to provide safe, effective, and painless treatments.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2012
- Employees
- 3
- Website
- ultrav.co.kr/
- Ownership
- Privately Held (backing)
Ultra V doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ultra V shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ultra V in its N-PORT filings yet. We sweep new filings monthly.